Quick Overview: The head of the pharmaceutical giant also discussed the company's pipeline, its artificial intelligence strategy, AI is playing a role in facilitating innovation in drug discovery and development at one of the world's largest biopharmaceutical ... Today's healthcare industry has gone from science fiction to science fact in a very short period of time. Gene editing, artificial ...

Sanofi Ceo Paul Hudson On - Detailed Overview & Context

The head of the pharmaceutical giant also discussed the company's pipeline, its artificial intelligence strategy, AI is playing a role in facilitating innovation in drug discovery and development at one of the world's largest biopharmaceutical ... Today's healthcare industry has gone from science fiction to science fact in a very short period of time. Gene editing, artificial ... Sanofi – Paul Hudson comments on Q3 2024 results

Photo Gallery

Sanofi CEO Paul Hudson: AI will improve efficiency and change the cost and speed of drug development
Sanofi CEO Paul Hudson on Q2 results, Dupixent demand and tariff impact
What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's
CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”
Sanofi CEO Paul Hudson on R&D Day: We're going to be the world's leading immunology company
Sanofi CEO Paul Hudson on Q3 results: The modernization effort is starting to pay off
Paul Hudson, Chief Executive Officer of Sanofi | Redefiners Podcast
Sanofi CEO Paul Hudson on the coronavirus, the FDA, drug development and more
Sanofi CEO Paul Hudson on Q3 results: Increased R&D spending will impact 2024 profit
Sanofi – Q3 2025 Results: Highlights from Paul Hudson
Sanofi CEO Paul Hudson on Q4 results: We've set ourselves up very well for 2025
Sanofi CEO Paul Hudson on Q2 results: Our underlying growth is still high-single digit
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored